Pharmaceutical Intermediate
-
Antitumor TM5614 /TM 5614/ TM-5614 Inhibitor CAS: 1190221-46-5
New arrival!
Email Details
Good quality!
IN STOCK -
Hot
-
Tacrolimus CAS 104987-11-3
Tacrolimus is an immunosuppressant medication used to prevent organ rejection in transplant patients. It is also available as a topical medication to treat skin conditions. Tacrolimus works by suppressing the immune system, and it is available in various forms such as capsules, tablets, injections, and ointments. Common side effects include headaches, nausea, diarrhea, high blood pressure, and tremors, and more severe side effects can occur.
Email Details -
Ivermectin CAS 70288-86-7
Ivermectin is an antiparasitic medication used to treat infections caused by roundworms, threadworms, scabies, and lice. It is also used in veterinary medicine to treat heartworms and other parasites. It has been recently controversially suggested as a treatment for COVID-19, but its efficacy is not yet confirmed.
Email Details -
Bleomycin sulfate CAS 9041-93-4
Bleomycin Sulfate (NSC125066) bleomycin sulfate is a glycopeptide antibiotic and an anticancer agent for squamous cell carcinoma (SCC) with IC50 of 4 nM in UT-SCC-19A cells.
Email Details -
-
Idoxuridine/5-Iodo-2'-deoxyuridine CAS: 54-42-2
Purity≥99.0%(by HPLC)99.77%
Email Details
Specific Rotation+28.00~ +32.00+28.80
lodide Content≤0.1 %Pass
Related Substances≤0.5%Pass
Other Substances≤0.5%Pass
Residue on lgnition≤0.1%Pass
Melting Point176℃ ~184℃Pass
Moisture Content≤1.0% w/w0.11%
PH5.5~6.5Pass -
2,3-Dichloro-5-(trifluoromethyl)pyridine CAS 69045-84-7
In recent years, new fluorine-containing pyridine pesticides have the advantages of broad-spectrum systemic absorption, high efficiency and low toxicity, and low pollution, and have become the backbone varieties of high-efficiency insecticides, herbicides and fungicides. 2,3-Dichloro-5-trifluoromethylpyridine (2,3,5-DCTF) is a key intermediate in the production of these novel pesticides
Email Details -
99% pharmacetical Danuglipron (PF-06882961) CAS:2230198-02-2
pharmaceutical Danuglipron (PF-06882961)
Email Details
min 9%
in stock
analysis report available